CASI Pharmaceuticals Stock

CASI Pharmaceuticals EBITDA per Employee

Delisted·Feb 25, 2026

The EBITDA per Employee of CASI Pharmaceuticals (CASI) as of Aug 22, 2026 is -316,824.00 USD. In the previous year, EBITDA per Employee was -200,640.00 USD — a change of 57.91% (lower).

EBITDA per Employee

-316,824.00USD

YoY

57.91%

Last updated:

EBITDA per Employee of CASI Pharmaceuticals is 2026 -316,824.00 USD. EBITDA per Employee of CASI Pharmaceuticals was 2025 -200,640.00 USD. It decreases by 57.91% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

CASI Pharmaceuticals Stock analysis

What does CASI Pharmaceuticals do? CASI Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CASI Pharmaceuticals stock

EBITDA per Employee of CASI Pharmaceuticals is -316,824.00 USD in 2026.

EBITDA per Employee of CASI Pharmaceuticals changed from -200,640.00 USD to -316,824.00 USD, representing a 57.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee CASI Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's CASI Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — CASI Pharmaceuticals

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — CASI Pharmaceuticals